Procurement

NHS National Framework for Transition products (Nilotinib and Ticagrelor)

  • NHS ENGLAND

Procurement identifier (OCID): ocds-h6vhtk-04ff90

Description

Project title: NHS National Framework for Transition products (Nilotinib and Ticagrelor) commencing 1st September 2025

Offer reference number: CM/TNS/24/5721

Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to maximum of 24 months.

Potential periods of call-offs under the framework agreement:

CM/TNS/24/5721/01 - Nilotinib and Ticagrelor

Lot 1 DCE/DNW/DNE: 01/09/2025 to 31/01/2027 (17 months)

Lot 2 DLN/DLS/DSW: 01/09/2025 to 31/01/2027 (17 months)

Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England

Please note that the contract had erroneously been advertised as an open framework at the tender stage and should have been advertised as a standalone framework.

Additional Unsuccessful supplier not listed due to technical error:

Torrent Pharma (UK) Ltd

Notices

UK6: Contract award notice

Notice identifier
2025/S 000-039270
Published
11 July 2025, 1:24pm

UK6: Contract award notice

Notice identifier
2025/S 000-039171
Published
11 July 2025, 10:52am

UK4: Tender notice

Notice identifier
2025/S 000-019321
Published
7 May 2025, 11:50am
Show all versions Hide all versions

UK2: Preliminary market engagement notice

Notice identifier
2025/S 000-013938
Published
9 April 2025, 12:44pm